Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

1.2K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.2K
Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

769
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
769
Menopause01:28

Menopause

5.1K
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
5.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

5.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.3K
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

7.8K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
7.8K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

5.7K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reproductive milestones across the lifespan and cardiovascular disease risk in women.

Climacteric : the journal of the International Menopause Society·2023
Same author

Compounded bioidentical menopausal hormone therapy - a physician perspective.

Climacteric : the journal of the International Menopause Society·2020
Same author

Do we have new preventive strategies for optimizing cardiovascular health in women?

Climacteric : the journal of the International Menopause Society·2019
Same author

Hormone replacement therapy (HRT)--risks and benefits.

International journal of epidemiology·2001
Same author

Can critically timed sleep deprivation be useful in pregnancy and postpartum depressions?

Journal of affective disorders·2000
Same author

Current indications for hormone replacement therapy.

The National medical journal of India·1999

Related Experiment Video

Updated: Mar 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K

Menopause, hormone therapy and diabetes.

C A Stuenkel1

  • 1a School of Medicine, Department of Medicine, Division of Endocrinology and Metabolism , University of California , San Diego , USA.

Climacteric : the Journal of the International Menopause Society
|January 10, 2017
PubMed
Summary
This summary is machine-generated.

Diabetes prevalence is rising, especially in aging populations and post-menopause. This review covers diabetes diagnosis, screening, and prevention strategies for midlife women, considering menopausal status and hormone therapy.

Keywords:
Menopausediabetesglucose controlmenopausal hormone therapy

More Related Videos

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.3K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.4K

Related Experiment Videos

Last Updated: Mar 9, 2026

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause
06:18

An In Vivo Estrogen Deficiency Mouse Model for Screening Exogenous Estrogen Treatments of Cardiovascular Dysfunction After Menopause

Published on: August 13, 2019

13.0K
A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice
14:26

A Method to Study the Impact of Chemically-induced Ovarian Failure on Exercise Capacity and Cardiac Adaptation in Mice

Published on: April 7, 2014

16.3K
Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats
08:56

Estrogen-Like Effect of Bazi Bushen Capsule in Ovariectomized Rats

Published on: April 7, 2023

1.4K

Area of Science:

  • Endocrinology
  • Women's Health
  • Metabolic Disorders

Background:

  • Global diabetes prevalence has quadrupled in 30 years, coinciding with obesity and an aging population.
  • Menopause and menopausal hormone therapies (MHT) significantly influence metabolic health and diabetes risk in women.
  • Diabetes exacerbates age-related health issues like cardiovascular disease, osteoporosis, and cancer in aging women.

Purpose of the Study:

  • To review current criteria and recommendations for diabetes diagnosis and screening.
  • To examine the impact of menopause and MHT on diabetes risk and glucose control in women.
  • To highlight evidence-based strategies for preventing diabetes in midlife women and managing associated chronic conditions.

Main Methods:

  • Comprehensive literature review of studies on diabetes, menopause, and hormone therapy.
  • Analysis of epidemiological data on diabetes prevalence and risk factors.
  • Synthesis of clinical guidelines for diabetes screening, prevention, and management in postmenopausal women.

Main Results:

  • Menopause is associated with increased diabetes risk in healthy women and affects the timing of menopause in established diabetes.
  • MHT can influence glucose control in women with diabetes and alter diabetes risk in menopausal women.
  • Diabetes significantly worsens chronic health concerns in aging women, necessitating integrated screening and prevention.

Conclusions:

  • Understanding the interplay of menopause, MHT, and diabetes is crucial for managing women's health.
  • Evidence-based strategies are available to prevent diabetes and mitigate its impact on aging women's health.
  • This review's findings are highly relevant to a significant portion of the postmenopausal patient population encountered by healthcare providers.